Cardiff, United Kingdom

Mike Looker

This inventor holds 1 USPTO granted patent. Top assignee: Ge Healthcare Limited. Active years: 2013.


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mike Looker - Innovator in NMR Spectroscopy

Introduction

Mike Looker is a notable inventor based in Cardiff, GB. He has made significant contributions to the field of Nuclear Magnetic Resonance (NMR) spectroscopy and Magnetic Resonance Imaging (MRI). His innovative work focuses on enhancing the sensitivity of NMR detection, which is crucial for studying biological systems.

Latest Patents

Mike Looker holds a patent for a method that investigates the fate of a test compound or the state of a biological system through NMR of hyperpolarized NMR active nuclei. This invention provides hyperpolarization methods that offer enhanced sensitivity over conventional NMR techniques. The methods are particularly beneficial for studying drug metabolism and toxicity. The increased sensitivity allows for the detection of test compounds at lower concentrations and saves substantial time in cases where extensive averaging is typically required to improve the signal-to-noise ratio of NMR spectra. This advancement opens up possibilities for studies that were previously impractical or impossible with conventional NMR.

Career Highlights

Mike Looker is associated with GE Healthcare Limited, where he applies his expertise in NMR spectroscopy. His work has been instrumental in advancing the capabilities of NMR technology in medical and research applications.

Collaborations

Some of his notable coworkers include Neil Cook and Jan Wolber, who have collaborated with him on various projects within the field.

Conclusion

Mike Looker's contributions to NMR spectroscopy represent a significant advancement in the field, enhancing the ability to study biological systems effectively. His innovative methods continue to impact research and medical diagnostics positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…